Krista Payne

Optimizing the Value of Observational Studies

Unlike controlled studies, observational studies have the potential to collect data on thousands – even millions – of patients.  Increasingly, manufacturers are asked for information and data that only these kinds of studies can provide.   

Observational studies can be used to help manufacturers and their stakeholders understand the clinical, patient-centered, and economic burden of disease, as well as the value of different treatments in reducing that burden. 

English

Study: Fatigue and Bone-Related Symptoms Most Impact the Health-Related Quality of Life of Patients with Multiple Myeloma

A study, designed and undertaken by medical and industry experts including Krista Payne and Noreen Lordan of UBC, assesses the health-related quality of life (HRQoL) of 154 patients with multiple myeloma (MM).  This cross-sectional, bi-national, multicenter study enrolled patients with MM presenting for routine care visits at five United Kingdom and six German sites.

English

What You Need to Know About Capturing Real-World Evidence through Chart Reviews

UBC experts Krista Payne MEd, Executive Director of Value Demonstration; Safety, Epidemiology, Registries and Risk Management and Principal Scientific Consultant, and Dara Stein, MSc, Senior Research Associate, Value Demonstration, Safety, Epidemiology, Registries and Risk Management, have written a comprehensive overview on retrospective chart studies online now at PharmaPhorum.com.

English

What We Learn, We Teach: Look for UBC at ICPE (International Conference on Pharmacoepidemiology and Therapeutic Risk Management)

UBC scientists never stop learning.  And, they never stop sharing what they’ve learned.  As healthcare professionals committed to improving patient outcomes, our scientists often use their research and studies for teaching opportunities. 

Congratulations to three of our clinical experts whose abstracts were selected for the upcoming ICPE conference

English
Subscribe to RSS - Krista Payne